Condition: Nasopharyngeal Carcinoma · PD-1 · Surgery · Sponsor: Sun Yat-sen University
Through multicenter, open-label, randomised clinical trials, we intend to demonstrate that PD-1 treatment added to salvage surgery could further decrease the rate of disease progression and improve the survival outcome of patients with resectable locally recurrent nasopharyngeal carcinoma compared with those treated with salvage surgery alone.
This description comes directly from the study's public registry record.
Ming-Yuan Chen, MD, PhD · 86-20-87343624 · chmingy@mail.sysu.edu.cn
You-Ping Liu, MD, PhD · 86-20-87343379 · liuyoup@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital, Sun Yat-Sen University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Nanfang Hospital of Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The Fifth Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The First People's Hospital of Foshan | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Zhongshan People's Hospital | Zhongshan, Guangdong, China | Not Yet Recruiting |
| The Tenth Affiliated Hospital, Sun Yat-Sen University | Nanchang, Jiangxi, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04778956